A research project supported by FAPESP and carried out at Harvard University in the United States has identified a set of metabolites that move from the intestine to the liver and then on to the heart, which distributes them throughout the body. These circulating compounds appear to influence how metabolic pathways function within the liver and how sensitive the body is to insulin. The findings point to potential new strategies for treating obesity and type 2 diabetes.